Akebia Therapeutics (AKBA)

Akebia Therapeutics Financial Statements


Akebia Therapeutics Financial Overview

Akebia Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.933; its P/E ratio is -0.34; Akebia Therapeutics is scheduled to report earnings on November 10, 2022, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 126.76M$ 61.70M$ 59.60M$ 48.76M$ 52.91M
Gross Profit$ 108.16M$ 30.36M$ 9.26M$ 32.81M$ 418.00K
EBIT$ 34.31M$ -57.36M$ -68.01M$ -54.46M$ -78.08M
EBITDA$ 43.74M$ -47.93M$ -58.56M$ -44.98M$ -68.57M
Net Income Common Stockholders$ 29.28M$ -62.42M$ -70.68M$ -59.54M$ -83.04M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 143.89M$ 149.80M$ 174.56M$ 207.20M$ 246.99M
Total Assets$ 521.80M$ 535.36M$ 525.55M$ 602.27M$ 611.86M
Total Debt$ 37.02M$ 37.90M$ 39.13M$ 105.68M$ 123.21M
Net Debt$ -106.87M$ -111.90M$ -135.43M$ -101.53M$ -123.78M
Total Liabilities$ 459.50M$ 509.24M$ 449.09M$ 465.12M$ 437.23M
Stockholders Equity$ 26.12M$ 62.30M$ 76.46M$ 137.15M$ 174.63M
Cash Flow
Free Cash Flow$ -30.66M$ -21.73M$ -62.81M$ -56.27M$ -63.14M
Operating Cash Flow$ -30.66M$ -21.62M$ -62.81M$ -56.27M$ -63.14M
Investing Cash Flow$ 0.00$ -114.00K$ 0.00$ 0.00$ 20.00M
Financing Cash Flow$ -9.00K$ 47.55M$ 5.40M$ 16.48M$ 37.37M
Currency in USD

Akebia Therapeutics Earnings and Revenue History

Akebia Therapeutics Debt to Assets

Akebia Therapeutics Cash Flow

Akebia Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis